Roger M. Ilagan

877 citations
17 papers · 687 indexed · h-index 12
Topics
Tissue Engineering and Regenerative Medicine (8 papers)Renal and related cancers (8 papers)Mesenchymal stem cell research (5 papers)
Partner nations
United States

In The Last Decade

Roger M. Ilagan

17 papers receiving 630 citations

Peers

Roger M. Ilagan
Comparison fields: 5 of 62
  • Molecular Biology 550
  • Surgery 227
  • Pulmonary and Respiratory Medicine 146
  • Genetics 107
  • Epidemiology 82
Replace Catherine Alexakis with:
Catherine Alexakis France
Daniëlle G. Leuning Netherlands
Xiumin Xu United States
Manuel Hermida‐Prieto Spain
Hirohito Mitsuyama Japan
Seiichiro Inoue Japan
Carmela Di Martino Italy
Martha J. Somerman United States
Tomoko Ohmori Japan
Hadil Al‐Jallad Canada
Roger M. Ilagan relative to Catherine Alexakis France Catherine Alexakis's profile →
Citations per field
00.5×5.1×
Catherine Alexakis · 1×
Citations per year

Countries citing papers authored by Roger M. Ilagan

Since Specialization
Citations

This map shows the geographic impact of Roger M. Ilagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger M. Ilagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger M. Ilagan more than expected).

Fields of papers citing papers by Roger M. Ilagan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger M. Ilagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger M. Ilagan. The network helps show where Roger M. Ilagan may publish in the future.

Co-authorship network of co-authors of Roger M. Ilagan

This figure shows the co-authorship network connecting the top 25 collaborators of Roger M. Ilagan. A scholar is included among the top collaborators of Roger M. Ilagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger M. Ilagan. Roger M. Ilagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 10
2 69
3 14
4 16
5 10
6 28
7 1
8 34
9 2
10 27
11 23
12 6
13 11
14 16
15 51
16 176
17 193

About Roger M. Ilagan

Roger M. Ilagan is a scholar working on Genetics, Nephrology and Surgery, having authored 17 papers that have together received 687 indexed citations. Recurring topics across this work include Tissue Engineering and Regenerative Medicine (8 papers), Renal and related cancers (8 papers) and Mesenchymal stem cell research (5 papers). The work is most often cited by research in Urology (61 citations), Molecular Biology (550 citations) and Genetics (80 citations). Roger M. Ilagan has collaborated with scholars based in United States. Frequent co-authors include Erik N. Meyers, Uta Grieshammer, Cristina Cebrián, Doris Herzlinger, Gail R. Martin, Doris Brown, Kai Jiao, Robert J. Schwartz, Yuping Yang and Radwan Abu‐Issa. Their work appears in journals such as PLoS ONE, Development and Journal of Cellular Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026